1932

Abstract

▪ Abstract 

The complete sequencing of the human genome is generating many novel targets for drug discovery. Understanding the pathophysiological roles of these putative targets and assessing their suitability for therapeutic intervention has become the major hurdle for drug discovery efforts. The dual-specificity phosphatases (DSPases), which dephosphorylate serine, threonine, and tyrosine residues in the same protein substrate, have important roles in multiple signaling pathways and appear to be deregulated in cancer and Alzheimer's disease. We examine the potential of DSPases as new molecular therapeutic targets for the treatment of human disease.

Keyword(s): Cdc25Cdkdrug discoveryMAPKMKP
Loading

Article metrics loading...

/content/journals/10.1146/annurev.pharmtox.45.120403.100040
2005-02-10
2024-04-20
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.pharmtox.45.120403.100040
Loading
/content/journals/10.1146/annurev.pharmtox.45.120403.100040
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error